Hubungan antara Modified Glasgow Prognostic Score (mGPS) dengan Stadium dan Derajat Diferensiasi Kanker Ovarium

https://doi.org/10.22146/jkr.63107

Bob Irsan(1*), Heru Pradjatmo(2), Muhammad Lutfi(3)

(1) Departemen Obstetri dan Ginekologi, FK-KMK, UGM
(2) Departemen Obstetri dan Ginekologi, FK-KMK, UGM
(3) Departemen Obstetri dan Ginekologi, FK-KMK, UGM
(*) Corresponding Author

Abstract


Background: Prognostic factors for ovarian cancer include residual tumor and chemotherapy response, but these parameters are not sufficient to predict ovarian cancer prognoses. A new approach such as mGPS that use a combination of CRP and albumin can be used to assess an inflammatory response. With mGPS, an elevated CRP value and hypoalbuminemia are poor prognosis.

 

Objective: To investigate the effect of mGPS on histopathologic staging and grading of ovarian cancer.

Method: The study design was a cross sectional study. The population of this study were patients with suspected ovarian cancer who underwent laparotomy surgical staging at RSUP Dr. Sardjito. The samples were patients with suspected ovarian cancer that have examined the hs-CRP level and albumin level preoperative,then underwent laparotomy surgical staging with histopathological results epithelial ovarian cancer. Data were analyzed using Chi Square test and logistic regression.

Results and Discussion: there were 57 subjects with epithelial ovarian cancer consisting of 25 subjects (43.86%) with high mGPS and 32 subjects (56.14%) with low mGPS. The value of mGPS is associated with the stage of ovarian cancer (p = 0.000; RP = 4.000 CI 95% = 2.195 – 7.289). The results of the multivariate analysis showed that the most important factor in determining the stage was mGPS (p = 0.000; RP = 3.818 95% CI = 1.544-6.092). While the most important factor in determining histopathologic grading of ovarian cancer was the type of ovarian tumor (p = 0.000; RP = 7.339 95% CI = 4.960-9.718).

Conclusion: There was an association between mGPS and the stage of ovarian cancer. The histopathologic grading was not influenced by mGPS, but was influenced by the type of ovarian tumor.

Keywords: mGPS; Stage; Histopathologic grading; Ovarian Cancer; Epithelial Type


Keywords


mGPS; Stage; Histopathologic grading; Ovarian Cancer; Epithelial Type

Full Text:

PDF


References

  1. Suhonen, K. Prognostic Role of Cell Adhesion Factors and Angiogenesis in Epithelial Ovarian Cancer. Doctoral Dissertation. Kuopio: University of Kuopio. Clinical Medicine, 2007
  2. Aziz MF, Andrijono, Saifuddinn AB. Buku acuan Nasional Onkologi Ginekologi. Yayasan Bina Pustaka Sarwono Prawirohardjo. Departemen Ginekologi dan ginekologi fakultas kedokteran Indonesia. Edisi pertama. 2006; 469 – 527
  3. Bugada, D., Allegri, M., Lavand’Homme, P., De Kock, M., & Fanelli, G. (2014). Inflammation-based scores: A new method for patient-targeted strategies and improved perioperative outcome in cancer patients. BioMed Research International, 2014. https://doi.org/10.1155/2014/142425
  4. Hashem, T.A., Shehata, M.A., Alhassanin, S.A., El-Menshawy, S.M., Gohar,
  5. Sharma, R., Hook, J., Kumar, M., & Gabra, H. (2008). Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer. European Journal of Cancer, 44(2), 251–256. https://doi.org/10.1016/j.ejca.2007.11.011

S.F.(2020). The prognostic value of Glasgow prognostic score in epithelial ovarian cancer. Menoufia Med J 33:699–705. DOI: 10.4103/mmj.mmj_264_19

  1. Omichi, C., Nakamura, K., Haraga, J., Masuyama, H., & Hiramatsu, Y. (2016). Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer. Cancer Medicine, 5(6), 1074–1080. https://doi.org/10.1002/cam4.681
  2. Adella, C.A., Simanjuntak, R.Y., and Adhisty, H.N. Luaran Kanker Ovarium

Berdasarkan Modifikasi Glasgow Prognostik Skor, Tesis PPDS I Obstetri dan Ginekologi FK USU. Medan, 2015.

  1. Zhu, J., Wang, H., Liu, C. C., Lu, Y., & Tang, H. (2016). The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study. Journal of Cancer Research and Clinical Oncology, 142(11), 2339–2345. https://doi.org/10.1007/s00432-016-2228-y
  2. Kurman, R. J., & Shih, I. M. (2010). The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. American Journal of Surgical Pathology, 34(3), 433–443. https://doi.org/10.1097/PAS.0b013e3181cf3d79
  3. Nakamura, K., Nakayama, K., Minamoto, T., Ishibashi, T., Sanuki, K., Yamashita, H., Ono, R., Sasamori, H., Komatsu‑Fujii, T., Ishikawa, M., & Kyo, S. (2018). High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma. Molecular and Clinical Oncology, 429–433. https://doi.org/10.3892/mco.2018.1551
  4. Hefler-Frischmuth, K., Seebacher, V., Polterauer, S., Tempfer, C., Reinthaller, A., & Hefler, L. (2010). The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer. European Journal of Obstetrics and Gynecology and Reproductive Biology, 149(1), 102–105. https://doi.org/10.1016/j.ejogrb.2009.12.027
  5. Nozoe, T., Matono, R., Ijichi, H., Ohga, T., & Ezaki, T. (2014). Glasgow prognostic score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma. International Surgery, 99(4), 512–517. https://doi.org/10.9738/INTSURG-D-13-00118.1
  6. Han, K. H., Park, N. H., Kim, J. J., Kim, S., Kim, H. S., Lee, M., & Song, Y. S. (2019). The power of the risk of ovarian malignancy algorithm considering menopausal status: A comparison with CA 125 and HE4. Journal of Gynecologic Oncology, 30(6), 1–9. https://doi.org/10.3802/jgo.2019.30.e83
  7. Berek JS, Friedlander M, Hacker NF. Epithelial Ovarian, Fallopian Tube,and Peritoneal Cancer, in berek and Hacker's Gynecologic Oncology, 16th Edition. Lippincott Williams & Wilkins, 2020: 2541-2619



DOI: https://doi.org/10.22146/jkr.63107

Article Metrics

Abstract views : 2479 | views : 2136

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Jurnal Kesehatan Reproduksi Indexed by:

 

 



SEKRETARIAT JURNAL KESEHATAN REPRODUKSI
Departemen Obstetri dan Ginekologi, FK-KMK, UGM/RS Dr. Sardjito
Jl. Kesehatan No. 1, Sekip Utara, Yogyakarta 55281
Tlp: (0274) 511329 / Faks: (0274) 544003
Email: jurnal.kesehatanreproduksi@ugm.ac.id
Cp: Dwi Astuti +6281802698043